Cite
HARVARD Citation
Xie, Z. et al. (2018). Design, synthesis and biological evaluation of 4-bromo-N-(3, 5-dimethoxyphenyl)benzamide derivatives as novel FGFR1 inhibitors for treatment of non-small cell lung cancer. Journal of enzyme inhibition and medicinal chemistry. pp. 905-919. [Online].